Publication | Closed Access

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer

Tailored S-1 MonotherapyElderly PatientsMedicineCancer ManagementPhase Ii StudyBronchial NeoplasmMetronomic ChemotherapyCancer TreatmentOncologyRadiation OncologyLung CancerRadiologyHealth Sciences